This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Etsuro Ito: Innovator in Alzheimer's Disease Diagnosis
Introduction
Etsuro Ito is a notable inventor based in Chevy Chase, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of Alzheimer's disease. His innovative approach utilizes human cells to enhance the accuracy of diagnosis for this debilitating condition.
Latest Patents
Etsuro Ito holds a patent for a method of diagnosing Alzheimer's disease. This invention focuses on detecting differences in potassium channels in cells from Alzheimer's patients compared to normal donors. Additionally, it examines variations in intracellular calcium concentrations in response to chemicals that are known to elevate these levels. This groundbreaking method aims to improve early detection and intervention for Alzheimer's disease.
Career Highlights
Etsuro Ito is affiliated with the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding of Alzheimer's disease and developing diagnostic tools that can lead to better patient outcomes. His dedication to research and innovation has positioned him as a key figure in the medical community.
Collaborations
Etsuro Ito has collaborated with esteemed colleagues such as Gary E. Gibson and Daniel L. Alkon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Etsuro Ito's contributions to the diagnosis of Alzheimer's disease exemplify the importance of innovation in medical research. His patented method represents a significant advancement in the field, offering hope for improved diagnostic capabilities. Through his work, he continues to make a lasting impact on the fight against Alzheimer's disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
